Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

13.23
+0.13000.99%
Post-market: 13.230.00000.00%19:16 EDT
Volume:410.78K
Turnover:5.39M
Market Cap:205.26M
PE:-4.15
High:13.28
Open:13.00
Low:12.90
Close:13.10
52wk High:16.77
52wk Low:11.95
Shares:15.52M
Float Shares:11.14M
Volume Ratio:0.63
T/O Rate:3.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1910
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:-3.27
PE(LYR):-4.15

Loading ...

Dyne Therapeutics Shares Rise After Novartis Reaches Deal to Buy Avidity

Dow Jones
·
Oct 28, 2025

BUZZ-U.S. STOCKS ON THE MOVE-PepGen, Turbo Energy, Qualcomm

Reuters
·
Oct 28, 2025

BUZZ-PepGen, Dyne rise after Novartis' $12 bln deal to buy rival Avidity

Reuters
·
Oct 27, 2025

Novartis' Avidity Deal Is a Green Light for Biotech Rally -- Barrons.com

Dow Jones
·
Oct 27, 2025

Avidity Biosciences downgraded to Neutral from Buy at Citi

TIPRANKS
·
Oct 27, 2025

Avidity Biosciences downgraded to Market Perform from Outperform at Leerink

TIPRANKS
·
Oct 27, 2025

Avidity Biosciences Inc : Leerink Partners Cuts to Market Perform From Outperform; Raises Target Price to $72 From $65

THOMSON REUTERS
·
Oct 27, 2025

Janus Henderson, Avidity Biosciences, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday

Benzinga
·
Oct 27, 2025

Avidity Biosciences Up Over 42%, on Track for Record High Close -- Data Talk

Dow Jones
·
Oct 27, 2025

Avidity Biosciences rises 42.8%

TIPRANKS
·
Oct 27, 2025

Avidity Biosciences Shares up About 43% After Novartis to Acquire Co for About $12 Bln

THOMSON REUTERS
·
Oct 27, 2025

Sector Update: Health Care Stocks Mixed Premarket Monday

MT Newswires Live
·
Oct 27, 2025

Novartis CEO Says Co Plans to Discuss Potential for Accelerated Approval With US FDA for Avidity's Fshd Therapy

THOMSON REUTERS
·
Oct 27, 2025

Novartis CEO, on Avidity Deal, Says "It's an Appropriate Risk to Take"

THOMSON REUTERS
·
Oct 27, 2025

Novartis CFO Says Avidity Deal in Line With Co's Strategy of Bolt-on Acquisitions- Conf Call

THOMSON REUTERS
·
Oct 27, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Keysight Technologies, Keurig Dr Pepper

Reuters
·
Oct 27, 2025

BREAKINGVIEWS-Novartis finds neat M&A cure for growth pains

Reuters
·
Oct 27, 2025

Top Premarket Gainers

MT Newswires Live
·
Oct 27, 2025

Avidity Biosciences- Upon Termination of Merger With Novartis Under Certain Circumstances, Co to Pay Novartis Termination Fee of $450 Mln

THOMSON REUTERS
·
Oct 27, 2025

S&P 500 Futures Climb In Premarket Trading; Avidity Biosciences, BridgeBio Pharma Lead

Dow Jones
·
Oct 27, 2025